Event Information  |  Chapters  |  Email  |  Download

Chapters:

A Phase I/II Vaccination With Type-I Scope of this web-lecture Scope of this web-lecture How does tumor vaccine work? Novel scientific aspects of this Bookmark 6 Bookmark 7 Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Interaction of aDC1, antigen-peptides and Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? HLA-A2-restricted Glioma Associated Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Why multiple antigens? Bookmark 31 Bookmark 32 Bookmark 33 Bookmark 34 Bookmark 35 Science behind the trial Scope of this web-lecture Eligible patients are ones who: Scope of this web-lecture Treatment schema Monitoring Preliminary Results Preliminary Results Preliminary Results The purpose of this clinical study The purpose of this clinical study The purpose of this clinical study The purpose of this clinical study The purpose of this clinical study Scope of this web-lecture Possible side effects Summary Summary Summary Summary Contact Information